(Q45750927)

15 December 2017

title

Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants (English)

1 reference

15 December 2017

0 references

vaccinia virus

1 reference

3

1 reference

15 December 2017

Peter Palese

5

1 reference

15 December 2017

Mariano Esteban

6

object named as

Esteban M

1 reference

15 December 2017

author name string

Gonzalo RM

1

1 reference

15 December 2017

Rodríguez D

2

1 reference

15 December 2017

Rodríguez JR

4

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

17

1 reference

15 December 2017

issue

7-8

1 reference

15 December 2017

page(s)

887-892

1 reference

15 December 2017

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Cytotoxic T lymphocytes against HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Structure of peptides associated with class I and class II MHC molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Candidate AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Characterization ofin VivoPrimary and Secondary CD8+T Cell Responses Induced by Recombinant Influenza and Vaccinia Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900274-6

7 January 2021

10.1016/S0264-410X(98)00274-6

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

10067695

1 reference

15 December 2017